• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ultrasound system represents vendor collaboration

Article

A new shared services system built around an advanced processing chip was released jointly at the RSNA meeting by TeraRecon and Fukuda-Denshi.

A new shared services system built around an advanced processing chip was released jointly at the RSNA meeting by TeraRecon and Fukuda-Denshi.

The UF-850XTD, a digital ultrasound system capable of cardiac and general imaging, offers continuous wave Doppler with high-frame-rate color flow imaging and a phased-array sector probe. The system uses high-frequency, convex, linear, and phased-array transducers and can be expanded to incorporate 3D imaging.

The midrange scanner is based on TeraRecon's XTrillion digital multibeam chip technology, which increases frame rates and axial resolution. The digital beam-forming technology also decreases noise to improve the sensitivity of images and the efficiency of ultrasound operators, particularly during the performance of Doppler studies. XTrillion digital signal processing coupled with tissue harmonics eliminates phase lapses that interfere with image sharpness.

The UF-850XTD comes with a 15-inch LCD or CRT monitor. Key configuration and placement have been designed to improve efficiency of operation and reduce musculoskeletal stress for the operator.

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Nina Kottler, MD, MS
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
© 2024 MJH Life Sciences

All rights reserved.